Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1500 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Tibotec Pharma Submits NDA For TMC278

Tibotec Pharma said that, TMC278 will be the third anti-HIV compound to be introduced by the company, if approved by FDA. Tibotec Pharma has applied for the approval

Clontech, TET Systems Expands License Agreement

The Tet-On 3G Inducible Expression System provides highly inducible, sensitive control of gene expression. The Tet-System includes two components, whose rights were acquired by TET an improved transcriptional